Innovent Approved to Start US Clinical Trial of CD47 Immunotherapy

Life Science

Fosun Pharma Officially Announces Plan for Henlius IPO in Hong Kong

Life Science

Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry

Life Science

Pfizer Snags FDA Approval for New Lung Cancer Drug Vizimpro

Life Science

Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

Life Science

Cellular Bio to Manufacture Novartis CAR-T Drug in China in $40 Million Deal

Life Science

F-Prime, Atlas lead cancer startup Akrevia to $30M A round

Life Science

Aphria closes deal, now worth up to $300 million, to acquire Scythian’s Latin American assets

Cannabis, Life Science

Lilly Licenses Chugai Pharma’s Oral Diabetes Drug for $50 Million Upfront

Life Science

Evoke Acquires Navience Healthcare Solutions, LLC

Life Science

Bellen Chemistry of Beijing, a CRO/CMO, Raises $30 Million-Plus in C Round

Life Science

Fosun Pharma Acquires China Rights to Stroke Drug in $32.5 Million Agreement

Life Science

Life Science & Technology Weekly 162 – Aurora Cannabis revenues more than triples to $19.1 million in fourth quarter

Life Science, Technology

Crop Secures THC License Portfolio at New 1,000 Acre Farm for Cultivation, Extraction, Commercial Kitchen and Retail

Cannabis, Life Science

CSPC Pharmaceutical Group Limited and Verastem Oncology Sign Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China

Life Science